(Total Views: 380)
Posted On: 02/25/2020 2:19:57 PM
Post# of 8397
Pulsed electromagnetic field therapy - Wikipedia
en.wikipedia.org › wiki › Pulsed_electromagnetic_field_therapy
22 hours ago - Pulsed electromagnetic field therapy (PEMFT), also known as low field magnetic stimulation ... The manufacturer of ActiPatch, Bioelectronics Corp, submitted 3 Clinical Studies to support the efficacy of ActiPatch relating to musculoskeletal pain, .
Research
Knee osteoarthritis
A 2013 review found that evidence was of very low quality, there might be a benefit for improved function, and there was no evidence for benefit for pain.
In 2017 the wearable ActiPatch PEMF Device was FDA 510k Cleared, Application # K152432, for "Adjunctive treatment of musculoskeletal pain related to: (1) plantar fasciitis of the heel; and (2) osteoarthritis of the knee". This Clearance was for Over the Counter use.
Depression
Use of pulsed electromagnetic field therapy has been studied for depression.
Postoperative Pain
In 2019 the wearable RecoveryRx PEMF Device was FDA Cleared, Application K190251, for "Adjunctive treatment of postoperative pain".
Musculoskeletal Pain
In January 2020 the wearable ActiPatch was granted FDA 510k Clearance, Application # K192234, for Over the Counter Marketing relating to "Adjunctive treatment of musculoskeletal pain", [17] . The manufacturer of ActiPatch, Bioelectronics Corp, submitted 3 Clinical Studies to support the efficacy of ActiPatch relating to musculoskeletal pain, .
https://en.wikipedia.org/wiki/Pulsed_electrom...ld_therapy
en.wikipedia.org › wiki › Pulsed_electromagnetic_field_therapy
22 hours ago - Pulsed electromagnetic field therapy (PEMFT), also known as low field magnetic stimulation ... The manufacturer of ActiPatch, Bioelectronics Corp, submitted 3 Clinical Studies to support the efficacy of ActiPatch relating to musculoskeletal pain, .
Research
Knee osteoarthritis
A 2013 review found that evidence was of very low quality, there might be a benefit for improved function, and there was no evidence for benefit for pain.
In 2017 the wearable ActiPatch PEMF Device was FDA 510k Cleared, Application # K152432, for "Adjunctive treatment of musculoskeletal pain related to: (1) plantar fasciitis of the heel; and (2) osteoarthritis of the knee". This Clearance was for Over the Counter use.
Depression
Use of pulsed electromagnetic field therapy has been studied for depression.
Postoperative Pain
In 2019 the wearable RecoveryRx PEMF Device was FDA Cleared, Application K190251, for "Adjunctive treatment of postoperative pain".
Musculoskeletal Pain
In January 2020 the wearable ActiPatch was granted FDA 510k Clearance, Application # K192234, for Over the Counter Marketing relating to "Adjunctive treatment of musculoskeletal pain", [17] . The manufacturer of ActiPatch, Bioelectronics Corp, submitted 3 Clinical Studies to support the efficacy of ActiPatch relating to musculoskeletal pain, .
https://en.wikipedia.org/wiki/Pulsed_electrom...ld_therapy
(0)
(0)
